The Other Half of the Duopoly
When a promo hands out an electronic design automation name, it usually names one company and leaves the obvious comparison sitting on the table. That comparison is Cadence Design Systems (CDNS), the other half of the EDA duopoly alongside Synopsys.
EDA is the software used to design chips. Every advanced processor, from the GPUs that train AI models to the custom accelerators companies build in-house, is drawn in these tools before it is ever manufactured. The market has consolidated around two dominant firms, and Cadence is one of them.
For a reader who was handed Synopsys as a free pick, understanding Cadence is how you tell whether the pick was a specific thesis or just a bet on a shared market.
What Cadence Does
Cadence’s business is close to Synopsys’ by design. Both companies sell the tools that handle the many stages of chip design, from logic verification to physical layout to sign-off before a chip goes to the fab.
The revenue model is the same too. Customers license the software, often under multi-year agreements, and the tools become embedded in the customer’s design flow. Once a team has built its process around a vendor, switching is expensive, which is why both incumbents enjoy high margins and recurring revenue.
The difference between the two is mostly in emphasis, not in kind. Cadence has particular strength in certain verification and custom-design niches, while Synopsys has historically leaned into synthesis and a large silicon intellectual property catalog. For most investors, the more useful statement is that they split a large, sticky market between them.
Why the Market Is Attractive
The appeal of EDA as a category is that it sits upstream of all the AI spending without betting on a winner. Whether the next generation of accelerators comes from Nvidia, from a wafer-scale challenger like Cerebras, or from a custom design at a hyperscaler, that chip still has to be designed in EDA software.
That means Cadence and Synopsys both benefit from the total volume of chip design, which only rises as AI keeps demanding more silicon. The AI chip stocks article maps the full layer stack, and it shows why the toolmakers are a distinct bet from the designers.
The honest caveat is that this durability is well understood and priced in. EDA names are not hidden bargains; they trade at rich multiples precisely because the market recognizes the quality of the business.
How Cadence Compares to the Pick
The promo’s free pick is Synopsys, the other duopoly leader. Cadence is the natural peer, with a comparable market position, a similar margin structure, and the same exposure to the chip-design cycle.
The Cadence vs Synopsys piece goes head-to-head on the two. The short version is that neither is an obvious wrong answer, and the choice usually comes down to valuation, specific product strength, and personal preference rather than a fundamental gap.
That is worth keeping in mind before treating a single EDA pick as a unique discovery. The promo names one name, but the market is a duopoly, and the competitor is sitting right there.
What to Watch
For a Cadence-focused investor, the signals are the same ones that matter across EDA. Watch design activity at the major chipmakers, the licensing and renewal trends, and the pace at which new AI accelerators get taped out.
For the full context on the promo that surfaced the EDA angle in the first place, the AI Super Chip teardown is the place to start.
Risks to the Story
The EDA duopoly is a quality business, but quality businesses still carry risks, and it is worth naming them before assuming the stock only goes up.
The first is cyclicality. Chip design activity is not perfectly steady, and a slowdown in customer spending flows through to tool revenue with a lag. The recurring license model softens the blow, but it does not remove it.
The second is concentration. Both duopoly leaders depend on a relatively small number of large semiconductor customers, and a pullback at any of the majors is felt quickly.
The third is simply price. The market understands how good this business is, and it prices the stock accordingly. Paying a rich multiple for a durable franchise can still produce a poor result if you buy at the wrong time. None of this changes the quality of the business; it just means the entry point matters as much as the story.
For an investor weighing Cadence, that is the balanced view. The category is excellent, the moat is real, and the risks are mostly about price and timing rather than the durability of the franchise itself.
Ready to see the research? Click here to access the Brownstone Research report.
NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.